Form 4: Cosmos Health CFO Increases Equity Stake

Cosmos Health CFO Georgios Terzis acquired 850,000 shares of common stock through the vesting of restricted stock units.

Summary

• Georgios Terzis, Chief Financial Officer of Cosmos Health Inc., acquired 850,000 shares of common stock on May 19, 2026.
• The acquisition resulted from the vesting of Restricted Stock Units (RSUs) granted under the company's 2024 & 2025 Omnibus Incentive Plan.
• Following this transaction, the CFO's total beneficial ownership of common stock increased to 2,067,263 shares.
• The transaction was executed at a price of $0.283 per share.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine executive compensation transaction rather than a change in company strategy or financial performance.

Positives

• Increased alignment between executive interests and shareholder value through higher equity ownership by the CFO.
• The transaction was conducted under an established incentive plan, indicating standard corporate governance practices.

Negatives

• The issuance of 850,000 shares represents potential dilution to existing shareholders.

Risks

• Reliance on equity-based compensation plans may impact future share dilution levels.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Management Comments

• The transaction was executed pursuant to the Issuer's 2024 & 2025 Omnibus Incentive Plan.

Industry Context

StockSavvy.ai notes that executive equity grants are standard practice in the healthcare and biotech sectors to retain key management talent, though investors should monitor the cumulative dilutive effect of such incentive plans.

Comparison to Industry Standards

• The use of Omnibus Incentive Plans for executive compensation is consistent with standard corporate governance practices for small-cap public companies.
• The vesting of RSUs upon grant is a common mechanism for executive retention in the industry.

Stakeholder Impact

• Shareholders may experience minor dilution due to the issuance of new shares under the incentive plan.

Next Steps

• Continued monitoring of insider transactions for potential shifts in management sentiment.

Key Dates

Keywords

Cosmos Health, COSM, Insider Trading, Form 4, Equity Compensation, CFO